1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow Graves' Orbitopathy: new trials by email Literature Review of Graves' Orbitopathy trials Research Report on Graves' Orbitopathy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Treatment of Graves' Orbitopathy (Thyroid Eye Disease) to Reduce Proptosis With Teprotumumab Infusions in a Randomized, Placebo-Controlled, Clinical Study Teprotumumab, Placebo - Thyroid Eye Disease, Graves' Orbitopathy | Phase 3 | Completed | Amgen | 83 | 2017-10-04 | 2024-07-11 |
Exophthalmos (1) · Graves Ophthalmopathy (1)
Autoimmune Diseases (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Endocrine System Diseases (1) · Eye Diseases (1) · Eye Diseases, Hereditary (1) · Genetic Diseases, Inborn (1) · Goiter (1) · Graves Disease (1) · Hyperthyroidism (1) · Immune System Diseases (1) · Orbital Diseases (1) · Thyroid Diseases (1)
Saline Solution (1) · teprotumumab (1)
Amgen (1)
Germany (1) · Italy (1) · United States (1)
2017 (1)